Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Prasugrel vs. High-Dose Clopidogrel in Hemodialysis Patients with Clopidogrel Resistance
NCT01155765Phase 3Completed
- Sponsor
- University of Patras
- Start
- May 2010
- Primary completion
- Jul 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of prasugrel in clopidogrel resistance (HTPR), sponsored by University of Patras. Primary endpoint: Platelet Reactivity Units at 30 days. Started May 2010; status: completed.
02
Drugs
prasugrel
03
Conditions
clopidogrel resistance (HTPR)
Beyond the preview
Go deeper on NCT01155765.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01155765.